Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001193125-25-327135

Principal Accounting Officer gave up 230 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Breedlove Robert Charles Principal Accounting Officer 2025-12-18 Shares withheld for taxes −230 $16.28 $3,744 47,844 D: show line 1 in the form
Loading xslF345X05/ownership.xml…